In health and biotech news:

🧬 The 7 most exciting cancer science and tech stories of 2022. Applying COVID-19 vaccine technology to cancer, CAR T-cell therapy keeps people cancer-free for a decade, and more - National Geographic

🔬 Moderna's mRNA skin cancer vaccine shows early promise in a new study. Coming off the success of its mRNA vaccine for COVID-19, Moderna announced on Dec. 13 that it achieved encouraging results when it turned its vaccine technology against cancer. - Time Magazine

💊 Overcoming the Biotech Investment Paradox. Big pharma companies have become more measured in their risk taking, with mergers and acquisitions gradually giving way to joint ventures and partnerships. - Pharmacy Times

👀 The biggest healthtech events to watch for in Q1 2023. - STAT

Latest healthtech and biotech deals 

The largest from last week:

🇨🇳 HighTide Therapeutics, a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, closed a $107M Series C financing round led by the TCM Healthcare Fund of Guangdong, managed by China Development Bank Capital.

🇺🇸 Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and related disorders, secured $80M in its latest funding round.

🇺🇸 Gold Kidney, a US-based special needs insurance platform, has raised $60M in its latest funding round.

Other notable deals from around the globe:

 🇫🇷 Volta Medical closed a Series B financing of €36M. Volta Medical develops AI tools that guide cardiac rhythmologists in the treatment of cardiac arrhythmias such as atrial fibrillation (AF).

🇺🇸 Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, closed a $35MSeries D financing round. 

Read up on all the latest health deals in Dealroom.co

Tip of the week

🦾 Dealroom Briefings: Giant leap for Exoskeleton tech

On Dealroom, we’ve mapped 24 exoskeleton tech startups, positioned to both capitalize from new regulatory momentum, and have a profound impact on the future of health and physiological rehab and motor enablement.

Dive into our Dealroom Briefing to learn more about this space and how it has expanded in countries like Germany.

Job opportunities

🇳🇱 At Dealroom.co we are hiring a Data Quality Reviewer and an Intelligence Analyst Intern and 3 other roles.

Discover 65K+ jobs openings at healthtech and biotech startups. (login for full results)

Dive in

💊📱 Top 100 Digital Therapeutics startups to watch

🌍 Healthtech’s decade: the MENA opportunity

👵🏼 The silver economy is in its prime

🩺 Medical education and training

Knowledge partners

Laura Rodriguez

Healthtech Specialist
Dealroom.co

Not a subscriber yet? 

This is Dealroom's weekly health newsletter.  Get more industry-specific intelligence on the evolving world of healthtech and biotech, emerging trends, and game-changing startups. Delivered on Fridays.